![Renejix CDMO Partner for Small Molecule Oral Dosage Forms](https://www.pharmacompass.com/image/flap/renejix-w35-desktop-header-01gif-33629.gif)
![Renejix CDMO Partner for Small Molecule Oral Dosage Forms](https://www.pharmacompass.com/image/flap/renejix-w35-mob-header-01gif-17728.gif)
API Suppliers
US DMFs Filed
0
CEP/COS Certifications
0
JDMFs Filed
0
EU WC
0
Listed Suppliers
0
0
USA (Orange Book)
0
Europe
0
Canada
0
Australia
0
South Africa
Uploaded Dossiers
0
U.S. Medicaid
0
Annual Reports
0
0
USFDA Orange Book Patents
0
USFDA Exclusivities
0
Blog #PharmaFlow
0
News
0
EDQM
0
USP
0
JP
0
Other Listed Suppliers
0
0
1. Alotec
2. Astmopent
3. Metaprel
4. Metaproterenol
5. Metaproterenol Polistirex
6. Metaproterenol Sulfate
7. Orciprenaline
8. Orciprenaline Sulfate
9. Polistirex, Metaproterenol
1. Prometa
2. Orciprenaline Sulphate
3. Th-152
4. Novasmasol
5. Metaprel
6. Alotec
7. [2-(3,5-dihydroxyphenyl)-2-hydroxyethyl]-propan-2-ylazanium;sulfate
8. Gj20h50yf0
9. Einecs 227-539-6
10. Unii-gj20h50yf0
11. 1-(3,5-dihydroxyphenyl)-2-(isopropylamino)ethanol Sulfate
12. 1-(3,5-dihydroxyphenyl)-1-hydroxy-2-isopropylaminoethane Sulfate
13. Metaproterenol Sulfate [usan:usp]
14. 3,5-dihydroxy-alpha-((isopropylamino)methyl)benzyl Alcohol Sulfate
15. 3,5-dihydroxy-alpha-((isopropylamino)methyl)benzyl Alcohol Sulfate (2:1)
16. (+-)-3,5-dihydroxy-alpha-((isopropylamino)methyl)benzyl Alcohol Sulfate (2:1)
17. 1,3-benzenediol, 5-(1-hydroxy-2-((1-methylethyl)amino)ethyl)-, Sulfate (2:1) (salt)
18. 1,3-benzenediol, 5-(1-hydroxy-2-((1-methylethyl)amino)ethyl)-, Sulfate (2:1) Salt
19. 1,3-benzenediol, 5-(1-hydroxy-2-(1-methylethyl)amino)ethyl-, (+-)-, Sulfate (2:1) (salt)
20. Benzyl Alcohol, 3,5-dihydroxy-alpha-((isopropylamino)methyl)-, Sulfate (2:1) (salt)
Molecular Weight | 520.6 g/mol |
---|---|
Molecular Formula | C22H36N2O10S |
Hydrogen Bond Donor Count | 8 |
Hydrogen Bond Acceptor Count | 10 |
Rotatable Bond Count | 8 |
Exact Mass | 520.20906652 g/mol |
Monoisotopic Mass | 520.20906652 g/mol |
Topological Polar Surface Area | 243 Ų |
Heavy Atom Count | 35 |
Formal Charge | 0 |
Complexity | 239 |
Isotope Atom Count | 0 |
Defined Atom Stereocenter Count | 0 |
Undefined Atom Stereocenter Count | 2 |
Defined Bond Stereocenter Count | 0 |
Undefined Bond Stereocenter Count | 0 |
Covalently Bonded Unit Count | 3 |
1 of 2 | |
---|---|
Drug Name | Metaproterenol sulfate |
Drug Label | Metaproterenol sulfate syrup is an oral bronchodilator. Each teaspoonful (5 mL), for oral administration, contains metaproterenol sulfate 10 mg. In addition, each teaspoonful (5 mL) contains the following inactive ingredients:citric acid, edetate dis... |
Active Ingredient | Metaproterenol sulfate |
Dosage Form | Tablet; Syrup; Solution |
Route | Oral; Inhalation |
Strength | 10mg/5ml; 0.4%; 0.6%; 10mg; 20mg |
Market Status | Prescription |
Company | Wockhardt; Silarx; Mylan Speclt; Par Pharm |
2 of 2 | |
---|---|
Drug Name | Metaproterenol sulfate |
Drug Label | Metaproterenol sulfate syrup is an oral bronchodilator. Each teaspoonful (5 mL), for oral administration, contains metaproterenol sulfate 10 mg. In addition, each teaspoonful (5 mL) contains the following inactive ingredients:citric acid, edetate dis... |
Active Ingredient | Metaproterenol sulfate |
Dosage Form | Tablet; Syrup; Solution |
Route | Oral; Inhalation |
Strength | 10mg/5ml; 0.4%; 0.6%; 10mg; 20mg |
Market Status | Prescription |
Company | Wockhardt; Silarx; Mylan Speclt; Par Pharm |
Adrenergic beta-2 Receptor Agonists
Compounds bind to and activate ADRENERGIC BETA-2 RECEPTORS. (See all compounds classified as Adrenergic beta-2 Receptor Agonists.)
Bronchodilator Agents
Agents that cause an increase in the expansion of a bronchus or bronchial tubes. (See all compounds classified as Bronchodilator Agents.)
Sympathomimetics
Drugs that mimic the effects of stimulating postganglionic adrenergic sympathetic nerves. Included here are drugs that directly stimulate adrenergic receptors and drugs that act indirectly by provoking the release of adrenergic transmitters. (See all compounds classified as Sympathomimetics.)
Tocolytic Agents
Drugs that prevent preterm labor and immature birth by suppressing uterine contractions (TOCOLYSIS). Agents used to delay premature uterine activity include magnesium sulfate, beta-mimetics, oxytocin antagonists, calcium channel inhibitors, and adrenergic beta-receptor agonists. The use of intravenous alcohol as a tocolytic is now obsolete. (See all compounds classified as Tocolytic Agents.)